Annual CFI
-$7.15 B
-$3.39 B-90.08%
31 December 2023
Summary:
Eli Lilly and Company annual cash flow from investing activities is currently -$7.15 billion, with the most recent change of -$3.39 billion (-90.08%) on 31 December 2023. During the last 3 years, it has fallen by -$4.89 billion (-216.65%). LLY annual CFI is now -475.27% below its all-time high of $1.91 billion, reached on 31 December 2018.LLY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$4.00 B
-$1.81 B-82.14%
30 September 2024
Summary:
Eli Lilly and Company quarterly cash flow from investing activities is currently -$4.00 billion, with the most recent change of -$1.81 billion (-82.14%) on 30 September 2024. Over the past year, it has dropped by -$924.20 million (-30.00%). LLY quarterly CFI is now -227.81% below its all-time high of $3.13 billion, reached on 30 June 2018.LLY Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$10.31 B
-$924.20 M-9.85%
30 September 2024
Summary:
Eli Lilly and Company TTM cash flow from investing activities is currently -$10.31 billion, with the most recent change of -$924.20 million (-9.85%) on 30 September 2024. Over the past year, it has dropped by -$5.13 billion (-99.26%). LLY TTM CFI is now -344.32% below its all-time high of $4.22 billion, reached on 30 September 2018.LLY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.1% | -30.0% | -99.3% |
| 3 y3 years | -216.7% | -549.6% | -237.1% |
| 5 y5 years | -475.3% | -845.0% | -18.4% |
LLY Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -216.7% | at low | -772.3% | at low | -293.1% | at low |
| 5 y | 5 years | -475.3% | +11.5% | -9573.2% | at low | -603.4% | at low |
| alltime | all time | -475.3% | +11.5% | -227.8% | +47.9% | -344.3% | at low |
Eli Lilly And Company Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.00 B(+82.1%) | -$10.31 B(+9.9%) |
| June 2024 | - | -$2.20 B(+86.7%) | -$9.38 B(+22.8%) |
| Mar 2024 | - | -$1.18 B(-59.7%) | -$7.64 B(+6.8%) |
| Dec 2023 | -$7.15 B(+90.1%) | -$2.92 B(-5.1%) | -$7.15 B(+38.3%) |
| Sept 2023 | - | -$3.08 B(+571.0%) | -$5.17 B(+69.8%) |
| June 2023 | - | -$459.10 M(-33.3%) | -$3.05 B(-10.8%) |
| Mar 2023 | - | -$688.80 M(-27.0%) | -$3.41 B(-9.3%) |
| Dec 2022 | -$3.76 B(+31.2%) | -$943.50 M(-1.2%) | -$3.76 B(+13.9%) |
| Sept 2022 | - | -$955.30 M(+15.6%) | -$3.30 B(+11.4%) |
| June 2022 | - | -$826.50 M(-20.3%) | -$2.96 B(+13.1%) |
| Mar 2022 | - | -$1.04 B(+114.3%) | -$2.62 B(-8.6%) |
| Dec 2021 | -$2.87 B(+26.9%) | -$484.20 M(-21.5%) | -$2.87 B(-6.2%) |
| Sept 2021 | - | -$616.50 M(+27.6%) | -$3.06 B(+11.0%) |
| June 2021 | - | -$483.30 M(-62.3%) | -$2.75 B(+11.0%) |
| Mar 2021 | - | -$1.28 B(+90.4%) | -$2.48 B(+9.9%) |
| Dec 2020 | -$2.26 B(-72.1%) | -$674.10 M(+115.0%) | -$2.26 B(+38.9%) |
| Sept 2020 | - | -$313.50 M(+49.0%) | -$1.63 B(-6.4%) |
| June 2020 | - | -$210.40 M(-80.2%) | -$1.74 B(+18.5%) |
| Mar 2020 | - | -$1.06 B(+2462.6%) | -$1.47 B(-81.9%) |
| Dec 2019 | -$8.08 B(-524.1%) | -$41.40 M(-90.2%) | -$8.08 B(-7.1%) |
| Sept 2019 | - | -$423.80 M(-794.8%) | -$8.70 B(+0.3%) |
| June 2019 | - | $61.00 M(-100.8%) | -$8.67 B(+54.8%) |
| Mar 2019 | - | -$7.68 B(+1065.2%) | -$5.60 B(-393.9%) |
| Dec 2018 | $1.91 B(-150.4%) | -$659.00 M(+65.5%) | $1.91 B(-54.8%) |
| Sept 2018 | - | -$398.10 M(-112.7%) | $4.22 B(+47.6%) |
| June 2018 | - | $3.13 B(-1939.9%) | $2.86 B(-213.2%) |
| Mar 2018 | - | -$170.30 M(-110.3%) | -$2.52 B(-33.3%) |
| Dec 2017 | -$3.78 B(+20.5%) | $1.65 B(-194.0%) | -$3.78 B(-42.8%) |
| Sept 2017 | - | -$1.76 B(-21.8%) | -$6.61 B(+17.0%) |
| June 2017 | - | -$2.25 B(+57.3%) | -$5.65 B(+27.8%) |
| Mar 2017 | - | -$1.43 B(+21.3%) | -$4.42 B(+40.9%) |
| Dec 2016 | -$3.14 B(<-9900.0%) | -$1.18 B(+48.2%) | -$3.14 B(+83.9%) |
| Sept 2016 | - | -$794.70 M(-22.2%) | -$1.71 B(+15.1%) |
| June 2016 | - | -$1.02 B(+602.1%) | -$1.48 B(+430.7%) |
| Mar 2016 | - | -$145.40 M(-157.3%) | -$279.40 M(-1142.5%) |
| Dec 2015 | $26.80 M(-100.7%) | $253.70 M(-144.5%) | $26.80 M(-101.1%) |
| Sept 2015 | - | -$570.10 M(-412.6%) | -$2.41 B(-31.0%) |
| June 2015 | - | $182.40 M(+13.4%) | -$3.49 B(-15.7%) |
| Mar 2015 | - | $160.80 M(-107.4%) | -$4.14 B(+5.8%) |
| Dec 2014 | -$3.91 B(+88.6%) | -$2.18 B(+32.1%) | -$3.91 B(+31.9%) |
| Sept 2014 | - | -$1.65 B(+251.8%) | -$2.96 B(+31.3%) |
| June 2014 | - | -$468.90 M(-220.7%) | -$2.26 B(-25.8%) |
| Mar 2014 | - | $388.40 M(-131.5%) | -$3.04 B(+46.6%) |
| Dec 2013 | -$2.07 B(-26.8%) | -$1.23 B(+30.6%) | -$2.07 B(-17.2%) |
| Sept 2013 | - | -$943.80 M(-24.6%) | -$2.50 B(+47.9%) |
| June 2013 | - | -$1.25 B(-192.4%) | -$1.69 B(+105.0%) |
| Mar 2013 | - | $1.36 B(-181.5%) | -$825.40 M(-70.9%) |
| Dec 2012 | -$2.83 B(-41.3%) | -$1.66 B(+1152.8%) | -$2.83 B(-7.0%) |
| Sept 2012 | - | -$132.70 M(-65.6%) | -$3.05 B(-22.3%) |
| June 2012 | - | -$385.30 M(-40.9%) | -$3.92 B(-27.8%) |
| Mar 2012 | - | -$652.30 M(-65.2%) | -$5.44 B(+12.7%) |
| Dec 2011 | -$4.82 B(+52.7%) | -$1.88 B(+86.1%) | -$4.82 B(+6.9%) |
| Sept 2011 | - | -$1.01 B(-46.9%) | -$4.51 B(+5.1%) |
| June 2011 | - | -$1.90 B(+4564.9%) | -$4.29 B(+36.4%) |
| Mar 2011 | - | -$40.70 M(-97.4%) | -$3.15 B(-0.4%) |
| Dec 2010 | -$3.16 B(-2312.7%) | -$1.56 B(+98.4%) | -$3.16 B(+70.8%) |
| Sept 2010 | - | -$788.50 M(+4.5%) | -$1.85 B(+86.2%) |
| June 2010 | - | -$754.20 M(+1333.8%) | -$993.40 M(+624.6%) |
| Mar 2010 | - | -$52.60 M(-79.3%) | -$137.10 M(-196.0%) |
| Dec 2009 | $142.80 M(-102.0%) | -$254.30 M(-475.6%) | $142.80 M(-102.8%) |
| Sept 2009 | - | $67.70 M(-33.7%) | -$5.07 B(+0.1%) |
| June 2009 | - | $102.10 M(-55.1%) | -$5.07 B(-15.7%) |
| Mar 2009 | - | $227.30 M(-104.2%) | -$6.01 B(-17.4%) |
| Dec 2008 | -$7.27 B(+67.9%) | -$5.47 B(-7734.5%) | -$7.27 B(+153.6%) |
| Sept 2008 | - | $71.60 M(-108.5%) | -$2.87 B(-20.2%) |
| June 2008 | - | -$840.10 M(-18.8%) | -$3.59 B(+23.6%) |
| Mar 2008 | - | -$1.03 B(-2.8%) | -$2.91 B(-32.8%) |
| Dec 2007 | -$4.33 B | -$1.06 B(+62.3%) | -$4.33 B(+65.9%) |
| Sept 2007 | - | -$655.70 M(+328.6%) | -$2.61 B(+49.8%) |
| June 2007 | - | -$153.00 M(-93.8%) | -$1.74 B(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$2.46 B(-474.9%) | -$1.68 B(-375.3%) |
| Dec 2006 | $608.40 M(-127.5%) | $655.00 M(+209.4%) | $608.40 M(-129.6%) |
| Sept 2006 | - | $211.70 M(-344.5%) | -$2.06 B(-33.7%) |
| June 2006 | - | -$86.60 M(-49.6%) | -$3.10 B(-26.4%) |
| Mar 2006 | - | -$171.70 M(-91.5%) | -$4.21 B(+90.0%) |
| Dec 2005 | -$2.22 B(+223.6%) | -$2.01 B(+141.4%) | -$2.22 B(-221.2%) |
| Sept 2005 | - | -$832.20 M(-30.5%) | $1.83 B(+25.2%) |
| June 2005 | - | -$1.20 B(-165.7%) | $1.46 B(-29.9%) |
| Mar 2005 | - | $1.82 B(-10.4%) | $2.08 B(-404.5%) |
| Dec 2004 | -$684.80 M(-48.6%) | $2.04 B(-269.6%) | -$684.80 M(-80.2%) |
| Sept 2004 | - | -$1.20 B(+109.1%) | -$3.47 B(+45.5%) |
| June 2004 | - | -$573.80 M(-39.4%) | -$2.38 B(+4.5%) |
| Mar 2004 | - | -$946.20 M(+27.0%) | -$2.28 B(+71.1%) |
| Dec 2003 | -$1.33 B(-46.2%) | -$745.20 M(+540.8%) | -$1.33 B(+6.6%) |
| Sept 2003 | - | -$116.30 M(-75.3%) | -$1.25 B(-53.3%) |
| June 2003 | - | -$471.00 M(<-9900.0%) | -$2.68 B(+16.1%) |
| Mar 2003 | - | $1.00 M(-100.2%) | -$2.30 B(-6.9%) |
| Dec 2002 | -$2.47 B(-37.6%) | -$663.00 M(-57.0%) | -$2.47 B(+7.7%) |
| Sept 2002 | - | -$1.54 B(+1455.7%) | -$2.30 B(+15.3%) |
| June 2002 | - | -$99.20 M(-41.3%) | -$1.99 B(-35.0%) |
| Mar 2002 | - | -$168.90 M(-65.2%) | -$3.07 B(-22.6%) |
| Dec 2001 | -$3.96 B(+275.3%) | -$485.20 M(-60.9%) | -$3.96 B(+29.7%) |
| Sept 2001 | - | -$1.24 B(+5.6%) | -$3.06 B(+12.1%) |
| June 2001 | - | -$1.17 B(+10.0%) | -$2.73 B(+18.4%) |
| Mar 2001 | - | -$1.07 B(-352.0%) | -$2.30 B(+118.0%) |
| Dec 2000 | -$1.06 B(-197.2%) | $423.20 M(-146.6%) | -$1.06 B(-36.7%) |
| Sept 2000 | - | -$908.30 M(+20.9%) | -$1.67 B(+92.4%) |
| June 2000 | - | -$751.00 M(-518.2%) | -$868.20 M(+194.3%) |
| Mar 2000 | - | $179.60 M(-194.3%) | -$295.00 M(-127.1%) |
| Dec 1999 | $1.09 B(-469.8%) | -$190.50 M(+79.2%) | $1.09 B(-7.3%) |
| Sept 1999 | - | -$106.30 M(-40.2%) | $1.17 B(+0.2%) |
| June 1999 | - | -$177.80 M(-111.4%) | $1.17 B(-11.1%) |
| Mar 1999 | - | $1.56 B(-1582.7%) | $1.32 B(-547.7%) |
| Dec 1998 | -$293.90 M(-136.3%) | -$105.30 M(-2.7%) | -$293.90 M(-35.5%) |
| Sept 1998 | - | -$108.20 M(+239.2%) | -$455.60 M(+22.4%) |
| June 1998 | - | -$31.90 M(-34.2%) | -$372.30 M(-149.1%) |
| Mar 1998 | - | -$48.50 M(-81.8%) | $759.00 M(-6.3%) |
| Dec 1997 | $809.70 M(-273.0%) | -$267.00 M(+972.3%) | $809.70 M(-15.4%) |
| Sept 1997 | - | -$24.90 M(-102.3%) | $957.10 M(+12.8%) |
| June 1997 | - | $1.10 B(>+9900.0%) | $848.60 M(-440.9%) |
| Mar 1997 | - | $2.20 M(-101.8%) | -$248.90 M(-46.8%) |
| Dec 1996 | -$468.00 M(-16.8%) | -$119.60 M(-10.3%) | -$468.00 M(-24.0%) |
| Sept 1996 | - | -$133.40 M(-7121.1%) | -$616.00 M(+22.9%) |
| June 1996 | - | $1.90 M(-100.9%) | -$501.10 M(-30.8%) |
| Mar 1996 | - | -$216.90 M(-18.9%) | -$723.90 M(+28.6%) |
| Dec 1995 | -$562.80 M(-87.2%) | -$267.60 M(+1346.5%) | -$562.80 M(-86.5%) |
| Sept 1995 | - | -$18.50 M(-91.6%) | -$4.16 B(-1.7%) |
| June 1995 | - | -$220.90 M(+295.9%) | -$4.23 B(-0.9%) |
| Mar 1995 | - | -$55.80 M(-98.6%) | -$4.26 B(-3.2%) |
| Dec 1994 | -$4.41 B(+408.2%) | -$3.86 B(+4224.4%) | -$4.41 B(+366.7%) |
| Sept 1994 | - | -$89.30 M(-65.3%) | -$943.90 M(+6.7%) |
| June 1994 | - | -$257.50 M(+31.0%) | -$884.50 M(+5.1%) |
| Mar 1994 | - | -$196.50 M(-50.9%) | -$841.80 M(-2.9%) |
| Dec 1993 | -$866.70 M(-6.6%) | -$400.60 M(+1239.8%) | -$866.70 M(+45.5%) |
| Sept 1993 | - | -$29.90 M(-86.1%) | -$595.50 M(-33.1%) |
| June 1993 | - | -$214.80 M(-3.0%) | -$889.90 M(+8.7%) |
| Mar 1993 | - | -$221.40 M(+71.1%) | -$819.00 M(-11.8%) |
| Dec 1992 | -$928.20 M(+8.5%) | -$129.40 M(-60.1%) | -$928.20 M(+6.8%) |
| Sept 1992 | - | -$324.30 M(+125.4%) | -$869.20 M(+13.5%) |
| June 1992 | - | -$143.90 M(-56.5%) | -$765.60 M(-19.0%) |
| Mar 1992 | - | -$330.60 M(+369.6%) | -$944.90 M(+10.4%) |
| Dec 1991 | -$855.70 M(-19.0%) | -$70.40 M(-68.1%) | -$855.70 M(-30.6%) |
| Sept 1991 | - | -$220.70 M(-31.7%) | -$1.23 B(-8.1%) |
| June 1991 | - | -$323.20 M(+33.9%) | -$1.34 B(+17.3%) |
| Mar 1991 | - | -$241.40 M(-46.1%) | -$1.14 B(+8.3%) |
| Dec 1990 | -$1.06 B(+28.0%) | -$447.70 M(+36.2%) | -$1.06 B(+73.6%) |
| Sept 1990 | - | -$328.70 M(+161.5%) | -$608.20 M(+117.6%) |
| June 1990 | - | -$125.70 M(-18.3%) | -$279.50 M(+81.7%) |
| Mar 1990 | - | -$153.80 M | -$153.80 M |
| Dec 1989 | -$824.80 M | - | - |
FAQ
- What is Eli Lilly and Company annual cash flow from investing activities?
- What is the all time high annual CFI for Eli Lilly and Company?
- What is Eli Lilly and Company annual CFI year-on-year change?
- What is Eli Lilly and Company quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly CFI year-on-year change?
- What is Eli Lilly and Company TTM cash flow from investing activities?
- What is the all time high TTM CFI for Eli Lilly and Company?
- What is Eli Lilly and Company TTM CFI year-on-year change?
What is Eli Lilly and Company annual cash flow from investing activities?
The current annual CFI of LLY is -$7.15 B
What is the all time high annual CFI for Eli Lilly and Company?
Eli Lilly and Company all-time high annual cash flow from investing activities is $1.91 B
What is Eli Lilly and Company annual CFI year-on-year change?
Over the past year, LLY annual cash flow from investing activities has changed by -$3.39 B (-90.08%)
What is Eli Lilly and Company quarterly cash flow from investing activities?
The current quarterly CFI of LLY is -$4.00 B
What is the all time high quarterly CFI for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly cash flow from investing activities is $3.13 B
What is Eli Lilly and Company quarterly CFI year-on-year change?
Over the past year, LLY quarterly cash flow from investing activities has changed by -$924.20 M (-30.00%)
What is Eli Lilly and Company TTM cash flow from investing activities?
The current TTM CFI of LLY is -$10.31 B
What is the all time high TTM CFI for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM cash flow from investing activities is $4.22 B
What is Eli Lilly and Company TTM CFI year-on-year change?
Over the past year, LLY TTM cash flow from investing activities has changed by -$5.13 B (-99.26%)